score, number of diseased vessels, critical lesions and total occlusions. Demographic and clinical profi le and laboratory data were collected for every patient. Cardiovascular risk factors were recorded according to standard defi nitions. Patients with history of IHD, heart failure, liver and kidney diseases, haematological or oncological disorders and chronic infections, taking diuretics, multivitamins, alcohol and on drugs interfering with serum uric acid levels were excluded from this study. Serum uric acid level was done after >8 hours of fasting and analysis was done by photometric technique with normal reference range of 3.5-6.5 mg/dl. Coronary angiography was performed through right femoral or right radial route by using Judkin's technique and on Bio-core (Siemens) and Integrus (Philips) machines in catheterization laboratory of Super-Speciality Wing Hospital of Burdwan Medical College in West Bengal, India, by experienced cardiologist unaware of clinical or biochemical profi le of patients. The Gensini score was used to evaluate the severity of atherosclerotic lesions on angiogram. The Gensini score was computed by assigning a severity score to each coronary stenosis according to the degree of luminal narrowing (visual assessment) (Table 1) . This number is then multiplied by a factor that takes into account the geographical importance of the lesion position in the coronary arterial tree ( Table 2 ). The Gensini score was then expressed as sum of scores of all coronary arteries. Critical lesion was defi ned as ≥70% stenosis involving proximal part of any of the three main coronary arteries or ≥50% of left main stem stenosis. Total occlusion was defi ned as 100% occlusion with no ante grade fl ow of contrast distal to the lesion. A vessel was counted as diseased vessel if it has ≥50% stenosis at any level. Statistical Analysis was performed using SPSS V version 20 for windows with appropriate methods. A 2-tailed P value < 0.05 was considered statistically signifi cant.
RESULTS
The prevalence of hyperuricemia in patients with CAD in this study was 42.68% (35 out of total 82 patients). The mean serum uric acid level was high in hyperuricemic group (serum uric acid > 6.5mg/dL) compared to normouricemic (serum uric acid <6.5 mg/dL) group (7.59±8.12 mg/dL vs. 4.83±0.66 mg/dL, p value <0.001) ( (Figure 1 ).
DISCUSSION
In this observational cross-sectional study we found association of hyperuricemia with the angiographic severity of CAD using Gensini scoring system. The higher serum uric acid levels was associated with higher Gensini score, frequent total occlusions and critical lesions in patients with Coronary Artery Disease compared to patients with normal uric acid level and also correlated with higher Gensini score and frequent total occlusions. Coronary angiography is the gold standard for diagnosis of CAD. Neeland IJ et al compare coronary angiographic scoring systems (Gensini) with intravascular ultrasound derived plaque burden in a CAD population undergoing angiographic evaluation and found strong correlation with each other and also with atherosclerotic plaque burden. 6 Sinning C et al also proposed that both Syntax scoring system and Gensini scoring system in combination with clinical variables could be used to predict the cardiovascular prognosis in CAD patients even during long-term follow-up. 7 Gensini coring systems therefore appear to be a valid estimate of CAD plaque burden. 6 Similar to our findings, Sinan DO et al also found association of serum uric acid level with the presence and severity of CAD. 8 Azmat EQ et al also reported the association of hyperuricemia with higher Gensini score, more frequent total occlusions and critical lesions in men presenting with acute coronary syndrome. 9 Duran M et al observed higher Gensini score, high number of diseased vessels, critical lesions, and total occlusion in hyperuricemic patients; serum uric acid level as independent predictor of multi vessel disease; and also the association of hyperuricemia with CAD severity even in non-diabetic and non-hypertensive patients. 10 Xiong Z et al used clinical SYNTAX severity scoring system and also found signifi cant association with the severity and complexity of CAD.
11
Contrary to our result Gur M et al concluded that uric acid level is associated with the presence but not with the severity of coronary artery disease. 12 Lu P et al observed a higher CAD severity in women having higher uric acid level, although uric acid was not independently associated with CAD or CAD severity either in women or in men. 13 Ndrepepa G et al concluded that uric acid level predicts an increased risk of cardiac mortality across all subgroups of patients with CAD and the association between uric acid level and cardiac or all-cause mortality had a 'J-shaped' pattern with lowest risk of death in patients with uric acid levels between 5·17 and < 6·76 mg/dL. 14 Kojima S et al suggest that hyperuricemia after AMI is associated with the development of heart failure. 15 Tamariz L et al found greater risk of atrial fi brillation in patients with elevated serum uric acid levels, particularly among blacks and women. 16 Demir B et al observed a positive correlation between severity of calcifi c aortic stenosis and serum uric acid levels. 17 A large scale prospective study is needed to determine the prognostic signifi cance of hyperuricemia over cardiovascular events.
CONCLUSION
In conclusion, we found association of Hyperuricemia with severity of CAD. The higher serum uric acid levels was associated with higher Gensini score, frequent total occlusions and critical lesions in patients with Coronary Artery Disease compared to patients with normal uric acid level and also correlated with higher Gensini score and frequent total occlusions. We suggest large scale prospective study to determine prognostic signifi cance of Hyperuricemia.
